Novago Therapeutics is rated 3 out of 5 in the category developing regenerative therapies for stroke. Read and write reviews about Novago Therapeutics. Novago Therapeutics is a Swiss biotech company pioneering the development of human antibody therapeutics against the protein Nogo-A: the most potent inhibitor of nerve fiber and vascular regeneration after injury of the central nervous system.
Company size
1-10 employees
Headquarters
Schlieren, ZH